Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Thoracic 4Gastrointestinal 4Other hematologic neoplasm 3Lymphoid 3Head & Neck 3Genitourinary 3Sarcoma 2Gynecologic 2CNS 2Plasma cell 1Other 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Brain Neoplasms 1702Glioblastoma 1308Glioma 995Neuroblastoma 408Central Nervous System Neoplasms 384Astrocytoma 384Gliosarcoma 286Oligodendroglioma 238Neoplasms 226Breast Neoplasms 216Meningioma 179Medulloblastoma 172Carcinoma, Non-Small-Cell Lung 149Recurrence 147Neoplasm Metastasis 138Lung Neoplasms 138Ependymoma 128Melanoma 119Sarcoma 117Neurofibromatosis 1 110Meningeal Carcinomatosis 107Lymphoma 95Neuroma, Acoustic 82Diffuse Intrinsic Pontine Glioma 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Head and Neck Neoplasms 79Ovarian Neoplasms 73Lymphoma, Follicular 73Pheochromocytoma 71Paraganglioma 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hypersensitivity × CNS × Clear all
NCT04700748 2021-01-08

Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) Metastases

Lund University Hospital

Phase NA Unknown
150 enrolled
CNS

Brain Neoplasms, Hypersensitivity

NCT03739333 2020-02-13

TIGRE

Hospices Civils de Lyon

Phase NA Unknown
40 enrolled
CNS

Glioblastoma, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡